top of page

Downloads

European Journal of Heart Failure (2024) - Cardiovascular toxicities of immune therapies for cancer– a scienti c statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology

Teresa López-Fernández, Irene Marco, Marianne C Aznar, Ana Barac, Jutta Bergler-Klein, Icro Meattini, Jessica M Scott, Daniela Cardinale, Susan Dent, Breast cancer and cardiovascular health, European Heart Journal, 2024;, ehae637, https://doi.org/10.1093/eurheartj/ehae637

Nitsche C, Hengstenberg C. Diagnostik und Therapie typischer Komplikationen der infektiösen Endokarditis AktuelKardiol2024;13:376–379|©2024.Thieme

Stroke recurrence after transcatheter PFO closure in patients with cryptogenic stroke International Journal of Stroke 1–11

Markart, S.; Hermann, A.; Chiari, F.; Heinz, G.; Speidl, W.S.; Lenz, M.; Hengstenberg, C.; Schellongowski, P.; Staudinger, T.; Zilberszac, R. Urinary Output as a Predictor of Mortality in Cardiogenic Shock: An Explorative Retrospective Analysis. J. Clin. Med. 2024, 13, 7706. https://doi.org/10.3390/jcm13247706

Lunzer,L.; Donà,C.; Mascherbauer, K.; Kronberger, C.; Nitsche, C.; Koschutnik, M.; Poledniczek, M.; Harbich, P.F.; Kaufmann,C.;Pogran,E.;etal. Renal T1TimesonCardiacMagnetic ResonanceReflectRenalDysfunction andAreAssociatedwithAdverse Outcomes: Insightsfroman All-ComerCohort. J. Clin. Med. 2025, 14, 154. https://doi.org/10.3390/ jcm14010154

Baumer, U.; Kazem, N.; Hammer, A.; Hofer, F.; Steinacher, E.; Koller, L.; Zimpfer, D.; Andreas, M.; Steinlechner, B.; Hengstenberg, C.; et al. Mid-Regional Pro-Adrenomedullin Is Associated with Adverse Cardiovascular Outcomes After Cardiac Surgery. J. Pers. Med. 2025, 15, 47. https:// doi.org/10.3390/jpm15020047

Mann, C.; Dachs, T.M.; Gharib, D.; Widmann, K.; Tosun, R.; Srdits, M.; Kronberger, C.; Beitzke, D.; Loewe, C.; Kammerlander, A.A.; et al. The Prognostic Implication of Late Gadolinium Enhancement Quantification and Syncope in Hypertrophic Cardiomyopathy. J. Clin. Med. 2025, 14, 1781. https://doi.org/10.3390/jcm14051781

Lustig, P.; Lee, J.; Sponder, M.; Stix, G.; Hengstenberg, C.; Schönbauer, R.; Stojkovic, S. Left Atrial Substrate Modification for Long-Standing Persistent Atrial Fibrillation and Left Atrial Macro- or Micro-Reentrant Tachycardia Using a Single-Shot Pulsed Field Ablation System—A Case Series. J. Clin. Med. 2025, 14, 1891. https://doi.org/10.3390/jcm14061891

Moreno, R., Souza, J., Smolnik, R. et al. Outcomes after TAVI in patients with atrial fibrillation and a history of recent PCI: Results from the ENVISAGE-TAVI AF trial. Clin Res Cardiol 114, 313–322 (2025). https://doi.org/10.1007/s00392-024-02379-5

Gender differences in the presentation and management of patients with severe aortic stenosis at specialist versus primary/sondary care centres: A sub-analysis of the IMPULSE enhanced registry, International Journal of Cardiology, 2025, 133223,

Koschutnik, M.; Brunner, C.; Nitsche, C.; Donà, C.; Dannenberg, V.; Halavina, K.; Koschatko, S.; Jantsch, C.; Mascherbauer, K.; Kronberger, C.; et al. Biomarkers of Inflammation and Association with Cardiovascular Magnetic Resonance Imaging for Risk Stratification and Outcome in Patients with Severe Aortic Stenosis. J. Clin. Med. 2025, 14, 2512. https://doi.org/10.3390/jcm14072512

Hamzaraj,K.;Demirel,C.; Domanig,A.;Graf,S.;Gyöngyösi,M.; Hengstenberg, C.; Frey, B.; Hemetsberger, R.RoleofFemoral Artery AccessCharacteristics and FemaleSexinIn-Hospital Complications for Patients UndergoingRecanalizationofChronic Total Occlusions. J. Clin. Med. 2025, 14, 4496. https://doi.org/10.3390/ jcm14134496

Poledniczek, M.;Hölzl, K.; Kronberger, C.; Ermolaev, N.; Schmid, L.M.; Rettl, R.; Binder, C.; Camuz Ligios, L.; Eslami, M.; Hengstenberg, C.; et al. Prevalence of Autonomic Dysfunction andCorrelationwith MarkersofDiseaseSeverity inCardiac Amyloidosis. J. Clin. Med. 2025, 14, 4682. https://doi.org/10.3390/ jcm14134682

Han E, Gyöngyösi M, Anwari E, Kokabi V, Gramser A, Spannbauer A, Fritzer-Szekeres M, Bergler-Klein J. A High-Sensitivity Troponin I Rapid Assay vs. a High-Sensitivity Troponin T Routine Assay in Acute Chest Pain Patients: A Prospective Monocentric Study. J Clin Med. 2025 May 15;14(10):3456. doi: 10.3390/jcm14103456. PMID: 40429452; PMCID: PMC12112038.

Schmitz-Dräger, B. J., Bismarck, E., Ebert, T., Starlinger, R., Dienes, K., Ottillinger, B., Goebell, P. J., Mühlich, S., Benderska-Söder, N., Bergler-Klein, J., & Hakenberg, O. W. (2025). Cardiovascular safety of GnRH agonist-based androgen deprivation therapy in a real-world setting: Results from a prospective cohort study (LEAN). Urologia Internationalis. Advance online publication. Han E, Gyöngyösi M, Anwari E, Kokabi V, Gramser A, Spannbauer A, Fritzer-Szekeres M, Bergler-Klein J. A High-Sensitivity Troponin I Rapid Assay vs. a High-Sensitivity Troponin T Routine Assay in Acute Chest Pain Patients: A Prospective Monocentric Study. J Clin Med. 2025 May 15;14(10):3456. doi: 10.3390/jcm14103456. PMID: 40429452; PMCID: PMC12112038.

Smit, R.A.J., Wade, K.H., Hui, Q. et al. Polygenic prediction of body mass index and obesity through the life course and across ancestries. Nat Med (2025). https://doi.org/10.1038/s41591-025-03827-z

Mascherbauer, K.; Kronberger, C.; Donà, C.; Koschutnik, M.; Dannenberg, V.; Poledniczek, M.; Lunzer, L.; Nitsche, C.; Duca, F.; Heitzinger, G.; et al. Comparative Assessment of CMR-Determined Extracellular Volume Metrics in Predicting Adverse Outcomes. J. Clin. Med. 2025, 14, 382. https://doi.org/10.3390/jcm14020382

Panagiotides, N.G.; Weidenhammer, A.; Prausmüller, S.; Stadler, M.; Spinka, G.; Heitzinger, G.; Arfsten, H.; Strunk, G.; Bartko, P.E.; Goliasch, G.; et al. Implementation of Medical Therapy in Different Stages of Heart Failure with Reduced Ejection Fraction: An Analysis of the VIENNA-HF Registry. Biomedicines 2025, 13, 1846. https://doi.org/10.3390/biomedicines13081846

Christopher Mann, Ulrike Pailer, Andreas Spannbauer, Fardin Hamidi, Aliza Veronika Braser, Martin Hülsmann, Christian Gerges, Michael Gottsauner-Wolf, Mariann Gyöngyösi, Markus Raderer, Martin Riesenhuber, Christian Hengstenberg, Jutta Bergler-Klein, Thomas A. Zelniker,Prognostic Value of Biomarkers in Cancer Patients Treated With Immune Checkpoint Inhibitor Therapy,JACC: Advances,Volume 4, Issue 9,2025,102022,ISSN 2772-963X,https://doi.org/10.1016/j.jacadv.2025.102022.

Mascherbauer K, Kronberger C, Gruber M, et al. Association between CMR-derived hepatic T1-time, tricuspid regurgitation and survival. Eur J Clin Invest. 2025; 00:e70106. doi:10.1111/eci.70106

(2025). Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-Oncology. European journal of heart failure. 10.1002/ejhf.70005.

Donà, C.; Rettl, R.; Binder-Rodriguez, C.; Dalos, D.; Kronberger, C.; Poledniczek, M.; Willixhofer, R.; Ermolaev, N.; Camuz-Ligios, L.; Agis, H.; et al. Coronary Artery Disease in Cardiac Amyloidosis: Prevalence, Clinical Relevance, and Cardiac Magnetic Resonance Imaging Features. J. Clin. Med. 2025, 14, 8802. https://doi.org/ 10.3390/jcm14248802

R. Hemetsberger, A. Maaroufi, K. Hamzaraj, et al., “ Bench Testing Analysis of Perforation Management in the Setting of Bifurcation Coronary Intervention,” Catheterization and Cardiovascular Interventions 0 (2025): 1-10. https://doi.org/10.1002/ccd.70406.

Comparative Performance of Machine Learning and Traditional Risk Scores in Predicting Adverse Events After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation
Nicolas, Johny et al., American Journal of Cardiology, Elsevier0002-9149, 10.1016/j.amjcard.2025.12.002, https://doi.org/10.1016/j.amjcard.2025.12.002

bottom of page